Clinical Trials Browser

Phase 1/2 × Neoplasms × XL147 × Clear all

NCT01587040 2022-04-19

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

Phase 1/2 Completed

61 enrolled 13 charts

Neoplasms